Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bias reduction in g-computation for covariate adjustment in randomized clinical trials.

Biometrics·2026

Same author

Toward Evidence Synthesis of Adverse Events in Imbalanced Time-to-Event Data.

Journal of evidence-based medicine·2026

Same author

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease.

Frontiers in immunology·2026

Same author

Trial design-aware funnel plot for publication bias assessment with noninferiority or equivalence objectives.

Journal of clinical epidemiology·2026

Same author

Unpublished trials affected evidence synthesis substantially when estimating medication harms in children.

Journal of clinical epidemiology·2026

Same author

The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons.

Research synthesis methods·2026

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Sensitivity to Excluding Treatments in Network Meta-analysis.

Lifeng Lin¹, Haitao Chu, James S Hodges

¹From the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN.

Epidemiology (Cambridge, Mass.)

|March 24, 2016

Summary

Arm-based network meta-analysis offers a robust alternative to contrast-based methods, particularly when treatments are excluded. This approach enhances performance by avoiding the exclusion of additional data from two-arm trials.

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: Mar 23, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

Biostatistics
Clinical Epidemiology
Health Services Research

Background:

Network meta-analysis (NMA) combines direct and indirect evidence from randomized controlled trials.
Contrast-based NMA commonly uses relative treatment effects (e.g., odds ratios) for binary outcomes.
Relative effects may not fully inform patient decision-making regarding efficacy and safety trade-offs.

Purpose of the Study:

To compare the performance of arm-based and contrast-based NMA methods when treatments are excluded from the network.
To empirically evaluate the influence of treatment exclusion on NMA results using published studies.

Main Methods:

Empirical examination of 14 published network meta-analyses.
Comparison of treatment exclusion impacts on both arm-based and contrast-based NMA approaches.
Analysis focused on a missing-data framework for estimating absolute treatment effects.

Main Results:

Substantial differences were observed between arm-based and contrast-based NMA when excluding treatments.
These differences are primarily driven by the handling of single-arm trials.
Contrast-based NMA necessitates excluding data from two-arm studies involving the removed treatment, unlike arm-based NMA.

Conclusions:

Arm-based NMA demonstrates superior performance and data utilization compared to contrast-based NMA when treatments are excluded.
The flexibility of arm-based NMA in handling treatment exclusions, especially concerning single-arm trials, is a significant methodological advantage.